Description: 의약품·의료용품·바이오 업종의 바이오의약품 및 바이오시밀러 연구개발 임상개발 사업
바이오 (57) biosimilar (43) 의료용품 (18) cell line development (14) 연구개발 (13) new drug development (3) 바이오의약 (1) 항체/단백질 치료제 (1) 유전자/세포치료제 (1) biologics medicine (1)
Announcement of base date and shareholder list closure period setting.
In accordance with Article 354 of the Commercial Act and Article 19 of our company's Articles of Incorporation, voting rights are granted to the shareholders listed in the shareholder register as of February 2, 2023. We hereby announce the suspension of changes in the stockholders' register, such as stock transfer, registration of pledge, change and cancellation of trust property, and indication and cancellation of trust property from February 3, 2023 to February 4, 2023 to confirm the right shareholders.
January 18, 2023